# Treatment of Children With Autistic Spectrum Disorder With Autologous Umbilical Cord Blood, a Pilot Study

> **NCT04243382** · PHASE2 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Autistic Spectrum Disorder

## Interventions

- **BIOLOGICAL:** Autologous umbilical cord blood
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT04243382
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-27
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04243382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04243382, "Treatment of Children With Autistic Spectrum Disorder With Autologous Umbilical Cord Blood, a Pilot Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04243382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*